Log in

Advaxis News Headlines (NASDAQ:ADXS)

$0.98
-0.04 (-3.94 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$0.93
Now: $0.98
$1.00
50-Day Range
$0.68
MA: $1.03
$1.30
52-Week Range
$0.21
Now: $0.98
$10.80
Volume4.60 million shs
Average Volume7.28 million shs
Market Capitalization$58.74 million
P/E RatioN/A
Dividend YieldN/A
Beta4.13

Headlines

Advaxis (NASDAQ ADXS) News Headlines

Source:
DateHeadline
BRIEF-Advaxis Announces Positive Clinical Data In Ongoing Phase 1/2 ADXS-503 Trial - ReutersBRIEF-Advaxis Announces Positive Clinical Data In Ongoing Phase 1/2 ADXS-503 Trial - Reuters
www.reuters.com - February 20 at 12:58 PM
Advaxis Announces Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at the IASLC 2020 Targeted Therapies of Lung Cancer Meeting - Yahoo FinanceAdvaxis Announces Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at the IASLC 2020 Targeted Therapies of Lung Cancer Meeting - Yahoo Finance
finance.yahoo.com - February 20 at 12:58 PM
Advaxis Announces Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at the IASLC 2020 Targeted Therapies of Lung Cancer MeetingAdvaxis Announces Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at the IASLC 2020 Targeted Therapies of Lung Cancer Meeting
finance.yahoo.com - February 20 at 12:58 PM
The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA DecisionsThe Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions
finance.yahoo.com - February 18 at 9:15 AM
Advaxis ADXS-PSA extends survival in prostate cancer patients - Seeking AlphaAdvaxis' ADXS-PSA extends survival in prostate cancer patients - Seeking Alpha
seekingalpha.com - February 13 at 4:02 PM
Form SC 13G Advaxis, Inc. Filed by: RENAISSANCE TECHNOLOGIES LLC - StreetInsider.comForm SC 13G Advaxis, Inc. Filed by: RENAISSANCE TECHNOLOGIES LLC - StreetInsider.com
www.streetinsider.com - February 13 at 11:01 AM
BRIEF-Advaxis Announces Updated Survival Data In Phase 1/2 ADXS-PSA Trial - ReutersBRIEF-Advaxis Announces Updated Survival Data In Phase 1/2 ADXS-PSA Trial - Reuters
www.reuters.com - February 13 at 11:01 AM
Advaxis Announces Updated Survival Data in Phase 1/2 ADXS-PSA Trial at the ASCO Genitourinary Cancers Symposium - GlobeNewswireAdvaxis Announces Updated Survival Data in Phase 1/2 ADXS-PSA Trial at the ASCO Genitourinary Cancers Symposium - GlobeNewswire
www.globenewswire.com - February 13 at 11:01 AM
Advaxis Announces Updated Survival Data in Phase 1/2 ADXS-PSA Trial at the ASCO Genitourinary Cancers SymposiumAdvaxis Announces Updated Survival Data in Phase 1/2 ADXS-PSA Trial at the ASCO Genitourinary Cancers Symposium
finance.yahoo.com - February 13 at 11:01 AM
BRIEF-Advaxis And Personalis Announce Agreement To Deploy Immunoid Next Platform - ReutersBRIEF-Advaxis And Personalis Announce Agreement To Deploy Immunoid Next Platform - Reuters
www.reuters.com - February 11 at 2:50 PM
Advaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program - Yahoo FinanceAdvaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program - Yahoo Finance
finance.yahoo.com - February 11 at 2:50 PM
Advaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program - GlobeNewswireAdvaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program - GlobeNewswire
www.globenewswire.com - February 11 at 8:40 AM
Data on Advaxis’ Clinical Programs to be Presented at Upcoming Medical Meetings - Yahoo FinanceData on Advaxis’ Clinical Programs to be Presented at Upcoming Medical Meetings - Yahoo Finance
finance.yahoo.com - January 30 at 12:03 PM
Data on Advaxis’ Clinical Programs to be Presented at Upcoming Medical MeetingsData on Advaxis’ Clinical Programs to be Presented at Upcoming Medical Meetings
finance.yahoo.com - January 30 at 12:03 PM
Advaxis down 15% on equity offering - Seeking AlphaAdvaxis down 15% on equity offering - Seeking Alpha
seekingalpha.com - January 21 at 9:57 PM
Advaxis, Inc. Announces Pricing of $10.5 Million Registered Direct Offering - GlobeNewswireAdvaxis, Inc. Announces Pricing of $10.5 Million Registered Direct Offering - GlobeNewswire
www.globenewswire.com - January 21 at 4:56 PM
Advaxis, Inc. Announces Pricing of $10.5 Million Registered Direct OfferingAdvaxis, Inc. Announces Pricing of $10.5 Million Registered Direct Offering
finance.yahoo.com - January 21 at 4:56 PM
APA, ADXS, KODK, and PACD among midday moversAPA, ADXS, KODK, and PACD among midday movers
seekingalpha.com - January 9 at 10:17 PM
APA, ADXS among premarket gainers - Seeking AlphaAPA, ADXS among premarket gainers - Seeking Alpha
seekingalpha.com - January 8 at 6:40 AM
Form 8-K Advaxis, Inc. For: Jan 07 - StreetInsider.comForm 8-K Advaxis, Inc. For: Jan 07 - StreetInsider.com
www.streetinsider.com - January 8 at 1:40 AM
Advaxis among healthcare gainers, Cassava Sciences leads the losers - Seeking AlphaAdvaxis among healthcare gainers, Cassava Sciences leads the losers - Seeking Alpha
seekingalpha.com - January 7 at 3:38 PM
Advaxis up 22% on advancement of prostate cancer candidate into the clinic - Seeking AlphaAdvaxis up 22% on advancement of prostate cancer candidate into the clinic - Seeking Alpha
seekingalpha.com - January 7 at 3:38 PM
Advaxis Announces FDA Clearance of IND for ADXS-504 for Treatment of Prostate Cancer - Yahoo FinanceAdvaxis Announces FDA Clearance of IND for ADXS-504 for Treatment of Prostate Cancer - Yahoo Finance
finance.yahoo.com - January 7 at 10:22 AM
Advaxis Announces FDA Clearance of IND for ADXS-504 for Treatment of Prostate CancerAdvaxis Announces FDA Clearance of IND for ADXS-504 for Treatment of Prostate Cancer
finance.yahoo.com - January 7 at 10:22 AM
Form SC 13G/A Advaxis, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.comForm SC 13G/A Advaxis, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
www.streetinsider.com - January 6 at 5:05 PM
Is Advaxis, Inc. (ADXS) A Good Stock To Buy? - Yahoo FinanceIs Advaxis, Inc. (ADXS) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - December 22 at 5:40 PM
Is Advaxis, Inc. (ADXS) A Good Stock To Buy?Is Advaxis, Inc. (ADXS) A Good Stock To Buy?
finance.yahoo.com - December 22 at 5:40 PM
Advaxis Reports Fiscal Year 2019 Financial Results and Provides a Business Update - Business WireAdvaxis Reports Fiscal Year 2019 Financial Results and Provides a Business Update - Business Wire
www.businesswire.com - December 20 at 6:10 PM
Did Changing Sentiment Drive Advaxiss (NASDAQ:ADXS) Share Price Down A Disastrous 99%? - Yahoo FinanceDid Changing Sentiment Drive Advaxis's (NASDAQ:ADXS) Share Price Down A Disastrous 99%? - Yahoo Finance
finance.yahoo.com - December 20 at 8:08 AM
Advaxis Reports Fiscal Year 2019 Financial Results and Provides a Business Update - Yahoo FinanceAdvaxis Reports Fiscal Year 2019 Financial Results and Provides a Business Update - Yahoo Finance
finance.yahoo.com - December 20 at 8:08 AM
Did Changing Sentiment Drive Advaxis's (NASDAQ:ADXS) Share Price Down A Disastrous 99%?Did Changing Sentiment Drive Advaxis's (NASDAQ:ADXS) Share Price Down A Disastrous 99%?
finance.yahoo.com - December 20 at 8:08 AM
Advaxis Reports Fiscal Year 2019 Financial Results and Provides a Business UpdateAdvaxis Reports Fiscal Year 2019 Financial Results and Provides a Business Update
finance.yahoo.com - December 20 at 8:08 AM
Advaxis to Present at 12th Annual LD Micro Main Event Investor Conference - Yahoo FinanceAdvaxis to Present at 12th Annual LD Micro Main Event Investor Conference - Yahoo Finance
finance.yahoo.com - December 5 at 7:26 AM
Advaxis to Present at 12th Annual LD Micro Main Event Investor Conference - Business WireAdvaxis to Present at 12th Annual LD Micro Main Event Investor Conference - Business Wire
www.businesswire.com - December 4 at 2:40 PM
Advaxis to Present at 12th Annual LD Micro Main Event Investor ConferenceAdvaxis to Present at 12th Annual LD Micro Main Event Investor Conference
finance.yahoo.com - December 4 at 9:39 AM
Advaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer - Yahoo FinanceAdvaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer - Yahoo Finance
finance.yahoo.com - December 3 at 1:05 PM
Advaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate CancerAdvaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer
finance.yahoo.com - December 3 at 1:05 PM
Advaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer - Business WireAdvaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer - Business Wire
www.businesswire.com - December 3 at 8:04 AM
Advaxis Announces Business and Pipeline Update - Business WireAdvaxis Announces Business and Pipeline Update - Business Wire
www.businesswire.com - October 24 at 1:42 PM
Advaxis Announces Business and Pipeline UpdateAdvaxis Announces Business and Pipeline Update
finance.yahoo.com - October 24 at 1:42 PM
Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research - Business WireAdvaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research - Business Wire
www.businesswire.com - October 10 at 1:46 PM
Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research - Yahoo FinanceAdvaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research - Yahoo Finance
finance.yahoo.com - October 10 at 8:45 AM
Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery ResearchAdvaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research
finance.yahoo.com - October 10 at 8:44 AM
Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial - Business WireAdvaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial - Business Wire
www.businesswire.com - October 7 at 1:51 PM
Advaxis (ADXS) Reports Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial - StreetInsider.comAdvaxis (ADXS) Reports Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial - StreetInsider.com
www.streetinsider.com - October 7 at 8:51 AM
Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial - Yahoo FinanceAdvaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial - Yahoo Finance
finance.yahoo.com - October 7 at 8:51 AM
Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA TrialAdvaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial
finance.yahoo.com - October 7 at 8:51 AM
Is This A Catalyst To Buy Advaxis, Inc. (NASDAQ:ADXS)? - Yahoo FinanceIs This A Catalyst To Buy Advaxis, Inc. (NASDAQ:ADXS)? - Yahoo Finance
finance.yahoo.com - September 21 at 5:45 PM
Is This A Catalyst To Buy Advaxis, Inc. (NASDAQ:ADXS)?Is This A Catalyst To Buy Advaxis, Inc. (NASDAQ:ADXS)?
finance.yahoo.com - September 21 at 7:43 AM
Dr. Robert Petit Follows His Passion to OS Therapies as Chief Medical & Scientific Advisor - Yahoo FinanceDr. Robert Petit Follows His Passion to OS Therapies as Chief Medical & Scientific Advisor - Yahoo Finance
finance.yahoo.com - September 18 at 4:09 PM
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Google Finance Portfolio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel